Literature DB >> 24075449

Meeting at the crossroads: common mechanisms in Fragile X and Down syndrome.

Karen T Chang1, Hyunah Ro, Wei Wang, Kyung-Tai Min.   

Abstract

Intellectual disability is characterized by significantly impaired cognitive abilities and is due to various etiological factors, including both genetic and non-genetic causes. Two of the most common genetic forms of intellectual disability are Fragile X syndrome (FXS) and Down syndrome (DS). Recent studies have shown that proteins altered in FXS and DS can physically interact and participate in common signaling pathways regulating dendritic spine development and local protein synthesis, thus supporting the notion that spine dysmorphogenesis and abnormal local protein synthesis may be molecular underpinnings of intellectual disability. Here we review the molecular constituents regulating local protein synthesis and spine morphology and their alterations in FXS and DS. We argue that these changes might ultimately affect synaptic homeostasis and alter cognitive performance.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24075449      PMCID: PMC4090020          DOI: 10.1016/j.tins.2013.08.007

Source DB:  PubMed          Journal:  Trends Neurosci        ISSN: 0166-2236            Impact factor:   13.837


  123 in total

Review 1.  Fragile X syndrome: loss of local mRNA regulation alters synaptic development and function.

Authors:  Gary J Bassell; Stephen T Warren
Journal:  Neuron       Date:  2008-10-23       Impact factor: 17.173

2.  Neurodevelopmental delay, motor abnormalities and cognitive deficits in transgenic mice overexpressing Dyrk1A (minibrain), a murine model of Down's syndrome.

Authors:  X Altafaj; M Dierssen; C Baamonde; E Martí; J Visa; J Guimerà; M Oset; J R González; J Flórez; C Fillat; X Estivill
Journal:  Hum Mol Genet       Date:  2001-09-01       Impact factor: 6.150

3.  Fragile X mental retardation protein is translated near synapses in response to neurotransmitter activation.

Authors:  I J Weiler; S A Irwin; A Y Klintsova; C M Spencer; A D Brazelton; K Miyashiro; T A Comery; B Patel; J Eberwine; W T Greenough
Journal:  Proc Natl Acad Sci U S A       Date:  1997-05-13       Impact factor: 11.205

4.  Metabotropic receptor-dependent long-term depression persists in the absence of protein synthesis in the mouse model of fragile X syndrome.

Authors:  Elena D Nosyreva; Kimberly M Huber
Journal:  J Neurophysiol       Date:  2006-02-01       Impact factor: 2.714

5.  Quantitative proteomic analysis of primary neurons reveals diverse changes in synaptic protein content in fmr1 knockout mice.

Authors:  Lujian Liao; Sung Kyu Park; Tao Xu; Peter Vanderklish; John R Yates
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-30       Impact factor: 11.205

Review 6.  Metabotropic glutamate receptors and fragile x mental retardation protein: partners in translational regulation at the synapse.

Authors:  Jennifer A Ronesi; Kimberly M Huber
Journal:  Sci Signal       Date:  2008-02-05       Impact factor: 8.192

7.  Craniofacial characteristics of fragile X syndrome in mouse and man.

Authors:  Inge Heulens; Michael Suttie; Andrei Postnov; Nora De Clerck; Concetta S Perrotta; Teresa Mattina; Francesca Faravelli; Francesca Forzano; R Frank Kooy; Peter Hammond
Journal:  Eur J Hum Genet       Date:  2012-12-05       Impact factor: 4.246

8.  The fragile X syndrome protein represses activity-dependent translation through CYFIP1, a new 4E-BP.

Authors:  Ilaria Napoli; Valentina Mercaldo; Pietro Pilo Boyl; Boris Eleuteri; Francesca Zalfa; Silvia De Rubeis; Daniele Di Marino; Evita Mohr; Marzia Massimi; Mattia Falconi; Walter Witke; Mauro Costa-Mattioli; Nahum Sonenberg; Tilmann Achsel; Claudia Bagni
Journal:  Cell       Date:  2008-09-19       Impact factor: 41.582

Review 9.  Dscam-mediated cell recognition regulates neural circuit formation.

Authors:  Daisuke Hattori; S Sean Millard; Woj M Wojtowicz; S Lawrence Zipursky
Journal:  Annu Rev Cell Dev Biol       Date:  2008       Impact factor: 13.827

10.  Overexpression of Down syndrome cell adhesion molecule impairs precise synaptic targeting.

Authors:  Vedrana Cvetkovska; Alexa D Hibbert; Farida Emran; Brian E Chen
Journal:  Nat Neurosci       Date:  2013-05-12       Impact factor: 24.884

View more
  8 in total

Review 1.  Dendritic spine dysgenesis in autism related disorders.

Authors:  Mary Phillips; Lucas Pozzo-Miller
Journal:  Neurosci Lett       Date:  2015-01-08       Impact factor: 3.046

2.  Teaching reading to youth with fragile X syndrome: Should phonemic awareness and phonics instruction be used?

Authors:  Allison Randel; Suzanne Adlof; Jessica Klusek; Jane Roberts
Journal:  EBP Briefs       Date:  2015-03

3.  A brain proteomic investigation of rapamycin effects in the Tsc1+/- mouse model.

Authors:  Hendrik Wesseling; Ype Elgersma; Sabine Bahn
Journal:  Mol Autism       Date:  2017-08-01       Impact factor: 7.509

4.  Distinct Defects in Spine Formation or Pruning in Two Gene Duplication Mouse Models of Autism.

Authors:  Miao Wang; Huiping Li; Toru Takumi; Zilong Qiu; Xiu Xu; Xiang Yu; Wen-Jie Bian
Journal:  Neurosci Bull       Date:  2017-03-03       Impact factor: 5.203

5.  Division of labor in the growth cone by DSCR1.

Authors:  Timothy S Catlett; Timothy M Gomez
Journal:  J Cell Biol       Date:  2016-05-23       Impact factor: 10.539

6.  DSCR1 is required for both axonal growth cone extension and steering.

Authors:  Wei Wang; Asit Rai; Eun-Mi Hur; Zeev Smilansky; Karen T Chang; Kyung-Tai Min
Journal:  J Cell Biol       Date:  2016-05-16       Impact factor: 10.539

7.  Inter-Dependent Mechanisms Behind Cognitive Dysfunction, Vascular Biology and Alzheimer's Dementia in Down Syndrome: Multi-Faceted Roles of APP.

Authors:  Dean Nizetic; Christopher L Chen; Wanjin Hong; Edward H Koo
Journal:  Front Behav Neurosci       Date:  2015-12-01       Impact factor: 3.558

Review 8.  Where Environment Meets Cognition: A Focus on Two Developmental Intellectual Disability Disorders.

Authors:  I De Toma; L Manubens-Gil; S Ossowski; M Dierssen
Journal:  Neural Plast       Date:  2016-07-28       Impact factor: 3.599

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.